- Home
- KRMD vs BDTX Comparison
KRMD vs BDTX Comparison
Compare KRMD & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- BDTX
- Stock Information
- Founded
- KRMD 1980
- BDTX 2014
- Country
- KRMD United States
- BDTX United States
- Employees
- KRMD N/A
- BDTX N/A
- Industry
- KRMD Medical/Dental Instruments
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRMD Health Care
- BDTX Health Care
- Exchange
- KRMD Nasdaq
- BDTX Nasdaq
- Market Cap
- KRMD 192.3M
- BDTX 181.4M
- IPO Year
- KRMD N/A
- BDTX 2020
- Fundamental
- Price
- KRMD $3.98
- BDTX $3.88
- Analyst Decision
- KRMD Strong Buy
- BDTX Strong Buy
- Analyst Count
- KRMD 4
- BDTX 5
- Target Price
- KRMD $4.63
- BDTX $10.40
- AVG Volume (30 Days)
- KRMD 76.9K
- BDTX 919.1K
- Earning Date
- KRMD 11-12-2025
- BDTX 11-05-2025
- Dividend Yield
- KRMD N/A
- BDTX N/A
- EPS Growth
- KRMD N/A
- BDTX N/A
- EPS
- KRMD N/A
- BDTX 0.25
- Revenue
- KRMD $36,848,451.00
- BDTX $70,000,000.00
- Revenue This Year
- KRMD $21.08
- BDTX N/A
- Revenue Next Year
- KRMD $16.37
- BDTX N/A
- P/E Ratio
- KRMD N/A
- BDTX $15.54
- Revenue Growth
- KRMD 19.57
- BDTX N/A
- 52 Week Low
- KRMD $1.86
- BDTX $1.20
- 52 Week High
- KRMD $5.05
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- KRMD 45.19
- BDTX 53.80
- Support Level
- KRMD $3.94
- BDTX $3.81
- Resistance Level
- KRMD $4.32
- BDTX $4.08
- Average True Range (ATR)
- KRMD 0.16
- BDTX 0.26
- MACD
- KRMD -0.02
- BDTX -0.05
- Stochastic Oscillator
- KRMD 12.34
- BDTX 29.74
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.